EUVIMEDEUVIMED entdecken
Crossref

N , N ‐Diarylsulfonamide Reduces Proinflammatory Cytokine Interleukin‐6 Levels in Cells through Nuclear Factor‐κB Regulation

Dattatraya A Babar, Gopinath Khansole, Vishal Kumar Singh, Akash Shinde, Kambhampati Vaishnavi, Andugulapati Sai Balaji, Haridas B Rode iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202300598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Dattatraya A Babar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural Products and Medicinal Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad, India-, 500007. Hauptthemen laut MEDLINE: NF-kappa B, Interleukin-6, Sulfonamides, Lipopolysaccharides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Deshbhakt Anandrao Balwantrao Naik Arts and Science College, Chikhali, Sangli, INSA, Department of Science and Technology, Government of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The arylsulfonamides were synthesized from aryl sulfonyl chloride and aromatic amines in dichloromethane in the presence of pyridine. The aryne chemistry was used to prepare diarylsulfonamide from arylsulfonamides and O ‐silylaryl triflate with CsF in acetonitrile at room temperature for 30 min. The synthesized compounds were evaluated for cytotoxicity followed by the cytokine/inflammatory marker's inhibition capability and its mechanism of action in RAW‐264.7 cells. Elevated interleukin‐6 (IL‐6) levels have been reported in inflammatory conditions and inflammation‐associated disorders. Hence, reducing the IL‐6 levels in inflammatory conditions can serve as an attractive therapeutic target in dealing the inflammation. Among 42 compounds, seven compounds showed significant inhibition of IL‐6 levels in lipopolysaccharide (LPS) challenged RAW‐264.7 cells at 12.5 μM concentration. Further, investigation revealed that the IC 50 value of these compounds for reducing IL‐6 levels was found to be in the range of 2.6 to 9.7 μM. The promising compounds 5y (IC 50 of 2.6 μM) and 5n (IC 50 of 4.1 μM) along with other derivatives fulfil drug‐likeness parameters laid down by Lipinski's rule of five. Further, RT‐qPCR and Western‐blot analysis revealed that treatment with 5n significantly reduced the expression of pro‐inflammatory, inflammatory and macrophage marker's expression (IL‐1β, CCL2, COX2 and CD68) compared to LPS control. The mechanistic evaluation showed that 5n exhibited anti‐inflammatory properties by modulating the nuclear factor‐κB (NF‐κB) activation. The identified compound can be a promising candidate for further discovery efforts to generate a preclinical candidate effective in inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BInterleukin-6SulfonamidesLipopolysaccharidesInterleukin-6 InhibitorsMiceAnimalsRAW 264.7 CellsStructure-Activity RelationshipMolecular StructureDose-Response Relationship, DrugAnti-Inflammatory AgentsHumans

Stichwörter der Autor:innen

Anti-inflammatory activityAryne chemistryDiarylsulfonamideInterleukin-6Sulfonamide

Substanzen

NF-kappa BInterleukin-6SulfonamidesLipopolysaccharidesAnti-Inflammatory AgentsInterleukin-6 Inhibitors

Autor:innen und Institutionen

  • Department of Natural Products and Medicinal Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad, India-, 500007.
  • Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201 002, India.
  • Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, 500 007, India.

ORCID-Profile: Haridas B Rode

Förderung

  • Deshbhakt Anandrao Balwantrao Naik Arts and Science College, Chikhali, Sangli
  • INSA
  • Department of Science and Technology, Government of India
  • CSIR-IICT
  • Indian National Science Academy

Zitieren

APA

Babar, D. A., Khansole, G., Kumar Singh, V., Shinde, A., Vaishnavi, K., Balaji, A. S., & Rode, H. B. (2024). N , N ‐Diarylsulfonamide Reduces Proinflammatory Cytokine Interleukin‐6 Levels in Cells through Nuclear Factor‐κB Regulation. ChemMedChem. https://doi.org/10.1002/cmdc.202300598

Vancouver

Babar DA, Khansole G, Kumar Singh V, Shinde A, Vaishnavi K, Balaji AS, et al. N , N ‐Diarylsulfonamide Reduces Proinflammatory Cytokine Interleukin‐6 Levels in Cells through Nuclear Factor‐κB Regulation. ChemMedChem. 2024. doi:10.1002/cmdc.202300598

BibTeX
@article{Babar2024,
  author = {Babar, Dattatraya A and Khansole, Gopinath and Kumar Singh, Vishal and Shinde, Akash and Vaishnavi, Kambhampati and Balaji, Andugulapati Sai and Rode, Haridas B},
  title = {N , N ‐Diarylsulfonamide Reduces Proinflammatory Cytokine Interleukin‐6 Levels in Cells through Nuclear Factor‐κB Regulation},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202300598}
}
Kostenlos starten →